This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Ribociclib with endocrine therapy improves survival in early-stage breast cancer
Read more
Faster diagnosis and treatment for skin cancer as NHS plans accelerated rollout of teledermatology
Read more
Continued smoking after cancer diagnosis increases risk of adverse CVD event
Read more
Two-thirds of patients correctly diagnosed with promising cancer blood test
Read more
Quitting smoking after renal cell carcinoma diagnosis improves prognosis
Read more
Medical cannabis effective for cancer-related pain according to real-world study
Read more
Research suggests asthmatics at increased risk of cancer
Read more
Return cancer test results within 10 days, NHS England tells hospitals
Read more
Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors
Read more
Objective response rate in advanced melanoma improved when vitamin D level normal
Read more
5-alpha reductase inhibitor use not linked to prostate cancer mortality
Read more
Both forms of cardiovascular disease associated with higher cancer risk
Read more
Pembrolizumab explored in the treatment of advanced biliary tract cancer
Read more
Adding ipilimumab to nivolumab of little value in recurrent or metastatic head and neck SCC
Read more
Psilocybin therapy effective for major depression among cancer patients
Read more
GD2-CART01 effective for R/R high-risk neuroblastoma
Read more
Neoadjuvant socazolimab shows promise for locally advanced oesophageal squamous cell cancer
Read more
Page 6 of 40
« First
«
...
4
5
6
7
8
...
20
30
40
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: